1. Home
  2. CCCC vs VMD Comparison

CCCC vs VMD Comparison

Compare CCCC & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$4.17

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Logo Viemed Healthcare Inc.

VMD

Viemed Healthcare Inc.

HOLD

Current Price

$9.84

Market Cap

369.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
VMD
Founded
2015
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
404.7M
369.2M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
CCCC
VMD
Price
$4.17
$9.84
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$12.20
N/A
AVG Volume (30 Days)
2.9M
237.7K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
16.45
32.14
EPS
N/A
0.06
Revenue
$35,947,000.00
$270,280,000.00
Revenue This Year
N/A
$17.88
Revenue Next Year
N/A
$14.98
P/E Ratio
N/A
$159.33
Revenue Growth
1.02
20.52
52 Week Low
$1.36
$5.93
52 Week High
$4.60
$10.18

Technical Indicators

Market Signals
Indicator
CCCC
VMD
Relative Strength Index (RSI) 62.85 55.50
Support Level $2.13 $9.22
Resistance Level N/A $10.05
Average True Range (ATR) 0.37 0.33
MACD 0.06 0.01
Stochastic Oscillator 70.09 84.17

Price Performance

Historical Comparison
CCCC
VMD

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

About VMD Viemed Healthcare Inc.

Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.

Share on Social Networks: